SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Citi Stays Bearish on Moderna After Full Melanoma Vaccine Data

Citi remains bearish on Moderna following the release of full melanoma vaccine data. Moderna shares extended their slide.

MRNA

Related stories